Randomised Open Label Study of Insulin Degludec Versus Insulin Glargine U100 in Ramadan
Stopped The study was terminated by the IRB and the Institutional Official after the MOPH and WCMQ audits
Conditions
Interventions
- DRUG: Insulin Degludec U100
- DRUG: Insulin Glargine
Sponsor
Weill Cornell Medical College in Qatar
Collaborators